Avg closing price
Price range

40 Ken Griffin Supernus Pharmaceuticals Trades

Ken Griffin acquired 7.6 Thousand Supernus Pharmaceuticals shares worth $256 Thousand. That's 0.00% of their equity portfolio (3960th largest holding). The first Supernus Pharmaceuticals trade was made in Q2 2013. Since then Ken Griffin bought shares 50 more times and sold shares on 45 occasions. The stake costed the investor $256 Thousand, netting the investor a gain of 0.1% so far.

Avg closing price
Price range
Sold 44.1% shares (-166 Thousand shares) Q4 2023
Avg closing price $26.51
Price range $22.72 - $29.68
Increased shares by 322.3% (+287 Thousand shares) Q3 2023
Avg closing price $30.44
Price range $27.57 - $32.91
Sold 14.6% shares (-15.2 Thousand shares) Q2 2023
Avg closing price $34.99
Price range $29.91 - $38.73
Sold 73.6% shares (-290 Thousand shares) Q1 2023
Avg closing price $38.45
Price range $34.93 - $42.03
Increased shares by 27.2% (+84.1 Thousand shares) Q4 2022
Avg closing price $34.75
Price range $31.09 - $37.88
Increased shares by 233.3% (+217 Thousand shares) Q3 2022
Avg closing price $32.54
Price range $28.79 - $35.51
Sold 12.6% shares (-13.3 Thousand shares) Q2 2022
Avg closing price $28.64
Price range $25.33 - $34.25
Sold 0.8% shares (-854 shares) Q1 2022
Avg closing price $30.66
Price range $28.51 - $32.90
Increased shares by 603.1% (+91.9 Thousand shares) Q4 2021
Avg closing price $30.34
Price range $26.37 - $34.22
Sold 96.2% shares (-389 Thousand shares) Q3 2021
Avg closing price $26.84
Price range $23.54 - $31.39
Increased shares by 675.6% (+352 Thousand shares) Q2 2021
Avg closing price $30.66
Price range $26.72 - $33.19
New holding (+52.2 Thousand shares) Q1 2021
Avg closing price $27.97
Price range $24.15 - $31.45
Sold -713 Thousand shares Q2 2020
Avg closing price $22.09
Price range $17.09 - $24.89
Increased shares by 153.7% (+432 Thousand shares) Q1 2020
Avg closing price $21.01
Price range $14.45 - $24.69
Increased shares by 22.8% (+52.2 Thousand shares) Q4 2019
Avg closing price $24.29
Price range $19.93 - $29.13
Increased shares by 70.1% (+94.4 Thousand shares) Q3 2019
Avg closing price $29.63
Price range $25.47 - $33.37
Sold 8.2% shares (-12.1 Thousand shares) Q2 2019
Avg closing price $34.26
Price range $29.96 - $38.87
Increased shares by 95.5% (+71.6 Thousand shares) Q1 2019
Avg closing price $37.21
Price range $32.77 - $41.99
Increased shares by 63.5% (+29.1 Thousand shares) Q4 2018
Avg closing price $43.00
Price range $30.84 - $49.51
Sold 39.2% shares (-29.6 Thousand shares) Q3 2018
Avg closing price $49.38
Price range $42.70 - $56.55

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!